Artivion Inc

NYSE:AORT   2:43:30 PM EDT
+0.32 (+2.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)524.26M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$79.85 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$12.92
50-Day MA$11.95
200-Day MA$17.93
See more pivots

Artivion Inc Stock, NYSE:AORT

1655 Roberts Boulevard NW, Kennesaw, Georgia 30144-3632
United States of America
Phone: +1.770.419.3355
Number of Employees: 1300


Artivion, Inc. focuses on developing solutions that address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment provides cardiac and vascular tissue preservation services. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.